<DOC>
	<DOCNO>NCT02630654</DOCNO>
	<brief_summary>This exploratory study aim evaluate diagnostic , prognostic response predictive value multi biomarker strategy patient Gastroenteropancreatic Neuroendocrine Tumors ( GEP NETs ) originate midgut pancreas . Using recently develop methodology enable evaluation 92 concomitant cancer biomarkers provide interesting approach solve question ( Lundberg et al 2011 ) .</brief_summary>
	<brief_title>Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs</brief_title>
	<detailed_description />
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Intestinal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Provision write informed consent prior study related procedure . Suspected suffer metastatic midgut NET Pancreatic nonfunctional NET ( WHO grade 1 2 , 10 % Ki67 ) . Male female age 18 old . Previously treat NET disease pharmaceutical treatment , Peptide Receptor Radionuclide Therapy ( PRRT ) radiation therapy ( surgery primary tumour accept ) Has mental condition render subject unable understand nature , scope possible consequence study , and/or evidence uncooperative attitude . Suffering malignant disease previously treat malignant disease within last 6 months.. Suffering chronic inflammatory disease . Suffering renal and/or liver disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>